Anis Karimpour-Fard
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 9 | 2015 | 588 | 1.050 |
Why?
| MicroRNAs | 9 | 2023 | 637 | 0.960 |
Why?
| Cardiomyopathy, Dilated | 6 | 2023 | 344 | 0.770 |
Why?
| Protein Interaction Mapping | 3 | 2008 | 104 | 0.680 |
Why?
| Software | 2 | 2015 | 613 | 0.660 |
Why?
| Circulating MicroRNA | 3 | 2023 | 23 | 0.560 |
Why?
| Proteomics | 6 | 2015 | 876 | 0.520 |
Why?
| DNA Copy Number Variations | 2 | 2018 | 167 | 0.510 |
Why?
| Hibernation | 5 | 2014 | 77 | 0.490 |
Why?
| Phylogeny | 4 | 2014 | 816 | 0.450 |
Why?
| Ventricular Remodeling | 3 | 2021 | 229 | 0.440 |
Why?
| Comparative Genomic Hybridization | 2 | 2018 | 28 | 0.420 |
Why?
| Gene Expression Profiling | 10 | 2021 | 1597 | 0.420 |
Why?
| Myocytes, Cardiac | 4 | 2021 | 472 | 0.420 |
Why?
| Sciuridae | 5 | 2014 | 145 | 0.400 |
Why?
| Escherichia coli | 6 | 2012 | 758 | 0.400 |
Why?
| Proteome | 3 | 2023 | 353 | 0.360 |
Why?
| Multigene Family | 3 | 2008 | 200 | 0.340 |
Why?
| Cluster Analysis | 6 | 2021 | 481 | 0.340 |
Why?
| MAP Kinase Kinase Kinases | 2 | 2021 | 71 | 0.320 |
Why?
| Seasons | 5 | 2014 | 461 | 0.320 |
Why?
| Sequence Analysis, Protein | 1 | 2007 | 31 | 0.310 |
Why?
| Superoxide Dismutase | 2 | 2020 | 339 | 0.300 |
Why?
| Data Collection | 1 | 2010 | 658 | 0.300 |
Why?
| DNA Helicases | 2 | 2021 | 131 | 0.300 |
Why?
| Gammaproteobacteria | 1 | 2007 | 14 | 0.300 |
Why?
| Metabolic Networks and Pathways | 5 | 2017 | 176 | 0.290 |
Why?
| Algorithms | 3 | 2008 | 1541 | 0.290 |
Why?
| Bacterial Proteins | 2 | 2010 | 759 | 0.280 |
Why?
| Oligonucleotide Array Sequence Analysis | 7 | 2012 | 770 | 0.280 |
Why?
| Genome, Bacterial | 4 | 2012 | 109 | 0.280 |
Why?
| Signal Transduction | 4 | 2023 | 4709 | 0.270 |
Why?
| Genome | 4 | 2014 | 277 | 0.260 |
Why?
| Escherichia coli Proteins | 3 | 2012 | 170 | 0.250 |
Why?
| Biomarkers | 6 | 2022 | 3588 | 0.240 |
Why?
| Models, Biological | 2 | 2008 | 1715 | 0.240 |
Why?
| Heart Defects, Congenital | 2 | 2021 | 703 | 0.220 |
Why?
| Arousal | 3 | 2012 | 157 | 0.220 |
Why?
| Transcriptome | 4 | 2021 | 756 | 0.220 |
Why?
| Heart Failure | 3 | 2023 | 1969 | 0.220 |
Why?
| DNA-Binding Proteins | 3 | 2021 | 1346 | 0.210 |
Why?
| Perforator Flap | 1 | 2022 | 19 | 0.210 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 119 | 0.210 |
Why?
| Species Specificity | 6 | 2008 | 565 | 0.200 |
Why?
| Bleomycin | 2 | 2020 | 228 | 0.200 |
Why?
| Focal Adhesions | 1 | 2021 | 44 | 0.200 |
Why?
| Fetofetal Transfusion | 1 | 2021 | 23 | 0.200 |
Why?
| Amniotic Fluid | 1 | 2021 | 68 | 0.200 |
Why?
| Mammaplasty | 1 | 2022 | 71 | 0.200 |
Why?
| Prostatic Neoplasms | 2 | 2021 | 940 | 0.200 |
Why?
| Milrinone | 1 | 2021 | 27 | 0.190 |
Why?
| Hypotension | 1 | 2022 | 120 | 0.190 |
Why?
| Genetic Variation | 4 | 2018 | 926 | 0.190 |
Why?
| Biological Products | 1 | 2023 | 170 | 0.190 |
Why?
| Heart Transplantation | 2 | 2018 | 671 | 0.190 |
Why?
| Phosphorylation | 3 | 2021 | 1633 | 0.190 |
Why?
| Evolution, Molecular | 4 | 2014 | 454 | 0.180 |
Why?
| Receptors, Androgen | 1 | 2021 | 134 | 0.180 |
Why?
| Calcium-Binding Proteins | 1 | 2021 | 217 | 0.180 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 77 | 0.180 |
Why?
| Keloid | 1 | 2019 | 7 | 0.170 |
Why?
| Dermis | 1 | 2019 | 29 | 0.170 |
Why?
| RNA Interference | 1 | 2021 | 460 | 0.170 |
Why?
| Chromatography, Liquid | 3 | 2016 | 355 | 0.170 |
Why?
| Myocardium | 2 | 2017 | 970 | 0.170 |
Why?
| Fever | 1 | 2020 | 283 | 0.170 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.170 |
Why?
| Animals | 23 | 2023 | 33381 | 0.160 |
Why?
| Mosaicism | 1 | 2018 | 62 | 0.160 |
Why?
| Inflammation | 2 | 2020 | 2566 | 0.160 |
Why?
| Ovarian Neoplasms | 1 | 2023 | 420 | 0.160 |
Why?
| Fluorouracil | 1 | 2019 | 151 | 0.160 |
Why?
| Gene Expression Regulation | 5 | 2018 | 2445 | 0.160 |
Why?
| Extracellular Matrix | 1 | 2021 | 446 | 0.160 |
Why?
| Cardiomyopathies | 1 | 2021 | 299 | 0.160 |
Why?
| Serum | 1 | 2018 | 63 | 0.150 |
Why?
| Humans | 32 | 2023 | 118974 | 0.150 |
Why?
| Heart Ventricles | 2 | 2021 | 727 | 0.150 |
Why?
| Databases, Genetic | 2 | 2015 | 253 | 0.150 |
Why?
| Acute Lung Injury | 1 | 2020 | 310 | 0.140 |
Why?
| Specimen Handling | 1 | 2018 | 165 | 0.140 |
Why?
| Reference Values | 2 | 2008 | 774 | 0.140 |
Why?
| Tandem Mass Spectrometry | 2 | 2016 | 421 | 0.140 |
Why?
| Ventricular Function, Right | 1 | 2018 | 257 | 0.140 |
Why?
| Energy Metabolism | 3 | 2023 | 767 | 0.140 |
Why?
| Plasma | 1 | 2018 | 224 | 0.140 |
Why?
| Real-Time Polymerase Chain Reaction | 5 | 2017 | 333 | 0.140 |
Why?
| Models, Genetic | 3 | 2008 | 595 | 0.140 |
Why?
| RNA, Messenger | 5 | 2021 | 2657 | 0.140 |
Why?
| Ethanol | 2 | 2012 | 575 | 0.130 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2018 | 527 | 0.130 |
Why?
| Calcium | 1 | 2021 | 1169 | 0.130 |
Why?
| Hylobates | 1 | 2014 | 5 | 0.130 |
Why?
| Karyotype | 1 | 2014 | 12 | 0.130 |
Why?
| Adrenergic beta-Antagonists | 1 | 2017 | 301 | 0.130 |
Why?
| Fetus | 1 | 2018 | 690 | 0.120 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2020 | 2062 | 0.120 |
Why?
| Down-Regulation | 2 | 2021 | 627 | 0.120 |
Why?
| Metabolomics | 2 | 2016 | 550 | 0.120 |
Why?
| Female | 20 | 2023 | 61565 | 0.120 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2014 | 112 | 0.120 |
Why?
| Heart | 2 | 2021 | 631 | 0.110 |
Why?
| Mutation | 5 | 2023 | 3457 | 0.110 |
Why?
| Lymphoma, T-Cell | 1 | 2012 | 22 | 0.110 |
Why?
| Drug Tolerance | 1 | 2012 | 78 | 0.110 |
Why?
| Amino Acids | 1 | 2016 | 465 | 0.110 |
Why?
| Lipectomy | 1 | 2012 | 9 | 0.110 |
Why?
| Fasting | 1 | 2014 | 264 | 0.110 |
Why?
| Dog Diseases | 1 | 2012 | 44 | 0.110 |
Why?
| Biomarkers, Tumor | 2 | 2023 | 1059 | 0.110 |
Why?
| Coronary Artery Disease | 1 | 2018 | 647 | 0.100 |
Why?
| Subcutaneous Fat | 1 | 2012 | 82 | 0.100 |
Why?
| Lymphoma, B-Cell | 1 | 2012 | 85 | 0.100 |
Why?
| Abdomen | 1 | 2012 | 110 | 0.100 |
Why?
| Breast Neoplasms | 2 | 2022 | 1965 | 0.100 |
Why?
| Ventricular Function, Left | 1 | 2015 | 468 | 0.100 |
Why?
| Morphogenesis | 1 | 2012 | 167 | 0.100 |
Why?
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 53 | 0.100 |
Why?
| Gluconeogenesis | 1 | 2011 | 66 | 0.100 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2016 | 702 | 0.100 |
Why?
| Gene Duplication | 3 | 2007 | 64 | 0.100 |
Why?
| Reproducibility of Results | 4 | 2018 | 2874 | 0.100 |
Why?
| Recovery of Function | 1 | 2015 | 604 | 0.100 |
Why?
| Bacterial Infections | 1 | 2012 | 227 | 0.100 |
Why?
| Gene Dosage | 2 | 2010 | 136 | 0.090 |
Why?
| Male | 16 | 2021 | 57801 | 0.090 |
Why?
| Sigma Factor | 1 | 2010 | 33 | 0.090 |
Why?
| Ligases | 1 | 2010 | 32 | 0.090 |
Why?
| Gene Regulatory Networks | 2 | 2023 | 239 | 0.090 |
Why?
| Glycolysis | 1 | 2011 | 224 | 0.090 |
Why?
| Blood Proteins | 1 | 2012 | 248 | 0.090 |
Why?
| Mice | 8 | 2023 | 15520 | 0.090 |
Why?
| Markov Chains | 1 | 2010 | 118 | 0.090 |
Why?
| Pancreas | 1 | 2012 | 282 | 0.090 |
Why?
| Child | 8 | 2022 | 19129 | 0.090 |
Why?
| Muscle Proteins | 1 | 2011 | 219 | 0.090 |
Why?
| Recombination, Genetic | 1 | 2010 | 173 | 0.090 |
Why?
| Oligonucleotides | 1 | 2010 | 140 | 0.090 |
Why?
| Adenosine Triphosphate | 1 | 2011 | 439 | 0.090 |
Why?
| Cell Line, Tumor | 3 | 2023 | 2851 | 0.080 |
Why?
| Escherichia coli K12 | 1 | 2008 | 7 | 0.080 |
Why?
| Genetic Enhancement | 1 | 2008 | 6 | 0.080 |
Why?
| DNA Repair | 1 | 2010 | 198 | 0.080 |
Why?
| Mice, Transgenic | 3 | 2023 | 2025 | 0.080 |
Why?
| Phenotype | 2 | 2023 | 3003 | 0.080 |
Why?
| Case-Control Studies | 3 | 2021 | 3171 | 0.080 |
Why?
| Polymorphism, Genetic | 1 | 2011 | 642 | 0.080 |
Why?
| Biostatistics | 1 | 2008 | 18 | 0.080 |
Why?
| Animals, Newborn | 2 | 2021 | 806 | 0.080 |
Why?
| Genomics | 1 | 2012 | 706 | 0.080 |
Why?
| Protein Engineering | 1 | 2008 | 107 | 0.070 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2012 | 814 | 0.070 |
Why?
| Computer Simulation | 2 | 2008 | 922 | 0.070 |
Why?
| Pneumonia | 1 | 2012 | 592 | 0.070 |
Why?
| Adiposity | 1 | 2012 | 516 | 0.070 |
Why?
| Shigella flexneri | 1 | 2007 | 11 | 0.070 |
Why?
| Chromosome Mapping | 1 | 2008 | 510 | 0.070 |
Why?
| Sequence Homology, Amino Acid | 1 | 2007 | 372 | 0.070 |
Why?
| Databases, Protein | 1 | 2007 | 60 | 0.070 |
Why?
| Macaca mulatta | 1 | 2007 | 153 | 0.070 |
Why?
| Likelihood Functions | 1 | 2007 | 136 | 0.070 |
Why?
| Primates | 1 | 2007 | 114 | 0.070 |
Why?
| DNA Probes | 1 | 2006 | 60 | 0.070 |
Why?
| Models, Statistical | 2 | 2008 | 636 | 0.070 |
Why?
| Forecasting | 1 | 2007 | 353 | 0.070 |
Why?
| Liver | 1 | 2014 | 1816 | 0.070 |
Why?
| Genome, Human | 1 | 2007 | 387 | 0.060 |
Why?
| Child, Preschool | 4 | 2021 | 9491 | 0.060 |
Why?
| Kidney | 1 | 2012 | 1353 | 0.060 |
Why?
| Echocardiography | 2 | 2021 | 556 | 0.060 |
Why?
| Cells, Cultured | 3 | 2018 | 4077 | 0.060 |
Why?
| Biofilms | 1 | 2007 | 231 | 0.060 |
Why?
| Sequence Analysis, DNA | 4 | 2010 | 755 | 0.060 |
Why?
| Rats, Sprague-Dawley | 2 | 2021 | 2478 | 0.060 |
Why?
| Prospective Studies | 3 | 2022 | 6471 | 0.060 |
Why?
| Biopsy | 2 | 2019 | 1079 | 0.060 |
Why?
| Receptors, Adrenergic | 1 | 2023 | 36 | 0.060 |
Why?
| Phosphoproteins | 2 | 2019 | 308 | 0.060 |
Why?
| Models, Theoretical | 1 | 2007 | 556 | 0.060 |
Why?
| Predictive Value of Tests | 1 | 2008 | 1868 | 0.060 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 106 | 0.060 |
Why?
| Sarcomeres | 1 | 2023 | 91 | 0.060 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 404 | 0.050 |
Why?
| Rats | 2 | 2021 | 5392 | 0.050 |
Why?
| Epigastric Arteries | 1 | 2022 | 15 | 0.050 |
Why?
| Up-Regulation | 2 | 2018 | 872 | 0.050 |
Why?
| Endopeptidase K | 1 | 2021 | 14 | 0.050 |
Why?
| Muscle, Skeletal | 1 | 2011 | 1515 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1167 | 0.050 |
Why?
| Ribonucleases | 1 | 2021 | 53 | 0.050 |
Why?
| Light Coagulation | 1 | 2021 | 7 | 0.050 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 34 | 0.050 |
Why?
| Fetoscopy | 1 | 2021 | 29 | 0.050 |
Why?
| Serum Response Factor | 1 | 2021 | 31 | 0.050 |
Why?
| Phenylthiohydantoin | 1 | 2021 | 40 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2014 | 2871 | 0.050 |
Why?
| Bacteria | 1 | 2007 | 757 | 0.050 |
Why?
| Microscopy, Atomic Force | 1 | 2021 | 118 | 0.050 |
Why?
| Body Temperature | 2 | 2012 | 215 | 0.050 |
Why?
| Adenosine Monophosphate | 1 | 2021 | 51 | 0.050 |
Why?
| DNA Primers | 2 | 2012 | 533 | 0.050 |
Why?
| Cardiac Output, Low | 1 | 2021 | 68 | 0.050 |
Why?
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.050 |
Why?
| Drainage | 1 | 2021 | 157 | 0.050 |
Why?
| Nitriles | 1 | 2021 | 155 | 0.050 |
Why?
| Benzamides | 1 | 2021 | 176 | 0.050 |
Why?
| RAW 264.7 Cells | 1 | 2020 | 42 | 0.050 |
Why?
| Blotting, Western | 2 | 2014 | 1194 | 0.050 |
Why?
| Infant | 3 | 2020 | 8293 | 0.050 |
Why?
| Cardiotonic Agents | 1 | 2021 | 127 | 0.050 |
Why?
| Ultrasonography, Prenatal | 1 | 2021 | 227 | 0.040 |
Why?
| Dopamine | 1 | 2022 | 249 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2020 | 114 | 0.040 |
Why?
| Androgens | 1 | 2021 | 167 | 0.040 |
Why?
| Immunoglobulins, Intravenous | 1 | 2020 | 128 | 0.040 |
Why?
| Mass Spectrometry | 2 | 2014 | 681 | 0.040 |
Why?
| Hominidae | 2 | 2014 | 99 | 0.040 |
Why?
| Injections, Intralesional | 1 | 2019 | 33 | 0.040 |
Why?
| HEK293 Cells | 1 | 2021 | 625 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 409 | 0.040 |
Why?
| Chemokine CCL2 | 1 | 2019 | 126 | 0.040 |
Why?
| Analysis of Variance | 2 | 2012 | 1293 | 0.040 |
Why?
| Phosphodiesterase 5 Inhibitors | 1 | 2018 | 36 | 0.040 |
Why?
| Cell Cycle | 1 | 2021 | 550 | 0.040 |
Why?
| Cohort Studies | 2 | 2022 | 5116 | 0.040 |
Why?
| Pregnancy | 2 | 2021 | 5691 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2012 | 1691 | 0.040 |
Why?
| Transcription Factors | 2 | 2019 | 1570 | 0.040 |
Why?
| Mice, Inbred C57BL | 2 | 2018 | 4908 | 0.040 |
Why?
| Pilot Projects | 1 | 2022 | 1419 | 0.040 |
Why?
| Freezing | 1 | 2018 | 87 | 0.040 |
Why?
| DNA Mutational Analysis | 1 | 2018 | 381 | 0.040 |
Why?
| Critical Illness | 1 | 2022 | 662 | 0.040 |
Why?
| Arenaviridae Infections | 1 | 2016 | 7 | 0.040 |
Why?
| Cell Degranulation | 1 | 2016 | 38 | 0.040 |
Why?
| Lymphocytic choriomeningitis virus | 1 | 2016 | 20 | 0.040 |
Why?
| Lectins, C-Type | 1 | 2016 | 63 | 0.040 |
Why?
| Adult | 4 | 2021 | 31512 | 0.040 |
Why?
| Granzymes | 1 | 2016 | 40 | 0.040 |
Why?
| Drug Resistance, Neoplasm | 1 | 2021 | 671 | 0.040 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 105 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 982 | 0.040 |
Why?
| Cytotoxicity, Immunologic | 1 | 2016 | 204 | 0.030 |
Why?
| Risk Factors | 2 | 2021 | 9000 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 394 | 0.030 |
Why?
| Recurrence | 1 | 2019 | 975 | 0.030 |
Why?
| Logistic Models | 1 | 2021 | 1901 | 0.030 |
Why?
| Pan troglodytes | 2 | 2007 | 57 | 0.030 |
Why?
| Hot Temperature | 1 | 2018 | 334 | 0.030 |
Why?
| Nucleic Acid Hybridization | 2 | 2007 | 193 | 0.030 |
Why?
| Prognosis | 2 | 2015 | 3443 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2021 | 900 | 0.030 |
Why?
| Cell Line | 1 | 2021 | 2707 | 0.030 |
Why?
| Chemokines | 1 | 2016 | 230 | 0.030 |
Why?
| Cellular Senescence | 1 | 2016 | 151 | 0.030 |
Why?
| Adolescent | 3 | 2021 | 18480 | 0.030 |
Why?
| Genotype | 1 | 2020 | 1882 | 0.030 |
Why?
| Transcription Termination, Genetic | 1 | 2014 | 11 | 0.030 |
Why?
| Retroelements | 1 | 2014 | 34 | 0.030 |
Why?
| Immunologic Memory | 1 | 2016 | 313 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 258 | 0.030 |
Why?
| Stroke Volume | 1 | 2017 | 513 | 0.030 |
Why?
| Cadherins | 1 | 2015 | 186 | 0.030 |
Why?
| Lymph Nodes | 1 | 2016 | 455 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 462 | 0.030 |
Why?
| Cell Proliferation | 1 | 2021 | 2275 | 0.030 |
Why?
| Retrospective Studies | 2 | 2022 | 12978 | 0.030 |
Why?
| Acetylation | 1 | 2014 | 217 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 473 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2021 | 2674 | 0.030 |
Why?
| Sirtuin 3 | 1 | 2014 | 60 | 0.030 |
Why?
| Lung | 2 | 2018 | 3664 | 0.030 |
Why?
| Mycoplasma pneumoniae | 1 | 2012 | 33 | 0.030 |
Why?
| CD146 Antigen | 1 | 2012 | 41 | 0.030 |
Why?
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2012 | 12 | 0.030 |
Why?
| Pneumonia, Mycoplasma | 1 | 2012 | 33 | 0.030 |
Why?
| Bacterial Load | 1 | 2012 | 61 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2012 | 89 | 0.030 |
Why?
| RNA, Neoplasm | 1 | 2012 | 77 | 0.030 |
Why?
| Selection, Genetic | 1 | 2014 | 252 | 0.030 |
Why?
| Peptide Library | 1 | 2012 | 80 | 0.030 |
Why?
| Skinfold Thickness | 1 | 2012 | 46 | 0.030 |
Why?
| alpha-Macroglobulins | 1 | 2012 | 24 | 0.030 |
Why?
| Body Fat Distribution | 1 | 2012 | 45 | 0.030 |
Why?
| Cystathionine beta-Synthase | 1 | 2012 | 60 | 0.030 |
Why?
| Receptors, Complement 3b | 1 | 2012 | 82 | 0.030 |
Why?
| Toll-Like Receptor 2 | 1 | 2012 | 127 | 0.030 |
Why?
| Adenoviridae | 1 | 2012 | 191 | 0.030 |
Why?
| In Situ Hybridization | 1 | 2012 | 311 | 0.030 |
Why?
| Young Adult | 2 | 2021 | 10793 | 0.030 |
Why?
| Immunophenotyping | 1 | 2012 | 278 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 2012 | 154 | 0.030 |
Why?
| Citric Acid Cycle | 1 | 2011 | 45 | 0.030 |
Why?
| Dogs | 1 | 2012 | 371 | 0.030 |
Why?
| Serum Albumin | 1 | 2012 | 146 | 0.030 |
Why?
| Aldehyde Dehydrogenase | 1 | 2012 | 134 | 0.030 |
Why?
| Thermogenesis | 1 | 2011 | 43 | 0.030 |
Why?
| Exons | 1 | 2012 | 307 | 0.020 |
Why?
| Hindlimb | 1 | 2011 | 137 | 0.020 |
Why?
| Heat-Shock Proteins | 1 | 2011 | 129 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
| Glycine | 1 | 2011 | 162 | 0.020 |
Why?
| DNA Barcoding, Taxonomic | 1 | 2010 | 17 | 0.020 |
Why?
| Acetyltransferases | 1 | 2010 | 21 | 0.020 |
Why?
| L-Lactate Dehydrogenase | 1 | 2010 | 112 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2020 | 3730 | 0.020 |
Why?
| Arginine | 1 | 2011 | 249 | 0.020 |
Why?
| Gene Library | 1 | 2010 | 127 | 0.020 |
Why?
| NAD | 1 | 2010 | 67 | 0.020 |
Why?
| Genetic Engineering | 1 | 2010 | 83 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2019 | 4596 | 0.020 |
Why?
| Gestational Age | 1 | 2012 | 765 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 502 | 0.020 |
Why?
| Macrophages, Alveolar | 1 | 2012 | 359 | 0.020 |
Why?
| Middle Aged | 3 | 2017 | 27617 | 0.020 |
Why?
| Genes | 1 | 2010 | 231 | 0.020 |
Why?
| Neoplasm Proteins | 1 | 2012 | 401 | 0.020 |
Why?
| Cell Differentiation | 1 | 2016 | 1753 | 0.020 |
Why?
| NF-kappa B | 1 | 2012 | 670 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 468 | 0.020 |
Why?
| Gene Deletion | 1 | 2010 | 361 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2011 | 477 | 0.020 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2010 | 279 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 282 | 0.020 |
Why?
| False Positive Reactions | 1 | 2008 | 115 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2490 | 0.020 |
Why?
| Radiographic Image Enhancement | 1 | 2008 | 65 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2484 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2010 | 940 | 0.020 |
Why?
| Mammography | 1 | 2008 | 126 | 0.020 |
Why?
| Neutrophils | 1 | 2012 | 1233 | 0.020 |
Why?
| Genetic Diseases, Inborn | 1 | 2007 | 46 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2007 | 141 | 0.020 |
Why?
| Base Sequence | 1 | 2010 | 2159 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2012 | 1323 | 0.020 |
Why?
| Heat-Shock Response | 1 | 2006 | 59 | 0.020 |
Why?
| Treatment Outcome | 1 | 2019 | 9342 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 1900 | 0.020 |
Why?
| Fibroblast Growth Factor 7 | 1 | 2004 | 17 | 0.020 |
Why?
| Pongo pygmaeus | 1 | 2004 | 7 | 0.020 |
Why?
| Chromosomes, Artificial, Bacterial | 1 | 2004 | 20 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2006 | 314 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 1012 | 0.020 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 103 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 2995 | 0.020 |
Why?
| Environment | 1 | 2006 | 346 | 0.020 |
Why?
| DNA, Complementary | 1 | 2004 | 268 | 0.010 |
Why?
| Quantitative Trait Loci | 1 | 2006 | 324 | 0.010 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2004 | 310 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2004 | 546 | 0.010 |
Why?
| Biomedical Research | 1 | 2007 | 612 | 0.010 |
Why?
| Sleep | 1 | 2006 | 660 | 0.010 |
Why?
| Biological Evolution | 1 | 2004 | 443 | 0.010 |
Why?
| Alcoholism | 1 | 2006 | 717 | 0.010 |
Why?
| Proteins | 1 | 2004 | 938 | 0.010 |
Why?
| Time Factors | 1 | 2007 | 6412 | 0.010 |
Why?
|
|
Karimpour-Fard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|